Literature DB >> 19817876

Deficit of heat shock transcription factor 1-heat shock 70 kDa protein 1A axis determines the cell death vulnerability in a model of spinocerebellar ataxia type 6.

Li Li1, Hironao Saegusa, Tsutomu Tanabe.   

Abstract

Spinocerebellar ataxia type 6 (SCA6) is caused by a small expansion of polyglutamine (polyQ)-encoding CAG repeat in Ca(v)2.1 calcium channel gene. To gain insights into pathogenic mechanism of SCA6, we used HEK293 cells expressing fusion protein of enhanced green fluorescent protein and Ca(v)2.1 carboxyl terminal fragment (EGFP-Ca(v)2.1CT) [L24 and S13 cells containing 24 polyQ (disease range) and 13 polyQ (normal range), respectively] and examined their responses to some stressors. When exposed to CdCl(2), L24 cells showed lower viability than the control S13 cells and caspase-dependent apoptosis was enhanced more in L24 cells. Localization of EGFP-Ca(v)2.1CT was almost confined to the nucleus, where it existed as speckle-like structures. Interestingly, CdCl(2) treatment resulted in disruption of more promyelocytic leukemia nuclear bodies (PML-NBs) in L24 cells than in S13 cells and in cells where PML-NBs were disrupted, aggregates of EGFP-Ca(v)2.1CT became larger. Furthermore, a large number of aggregates were formed in L24 cells than in S13 cells. Results of RNAi experiments indicated that HSPA1A determined the difference against CdCl(2) toxicity. Furthermore, protein expression of heat shock transcription factor 1 (HSF1), which activates HSPA1A expression, was down-regulated in L24 cells. Therefore, HSF1-HSPA1A axis is critical for the vulnerability in L24 cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19817876     DOI: 10.1111/j.1365-2443.2009.01348.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  8 in total

1.  Bicistronic CACNA1A Gene Expression in Neurons Derived from Spinocerebellar Ataxia Type 6 Patient-Induced Pluripotent Stem Cells.

Authors:  Carlo Bavassano; Andreas Eigentler; Ruslan Stanika; Gerald J Obermair; Sylvia Boesch; Georg Dechant; Roxana Nat
Journal:  Stem Cells Dev       Date:  2017-10-30       Impact factor: 3.272

Review 2.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 3.  Regulation of heat shock transcription factors and their roles in physiology and disease.

Authors:  Rocio Gomez-Pastor; Eileen T Burchfiel; Dennis J Thiele
Journal:  Nat Rev Mol Cell Biol       Date:  2017-08-30       Impact factor: 94.444

Review 4.  Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.

Authors:  David D Bushart; Geoffrey G Murphy; Vikram G Shakkottai
Journal:  Ann Transl Med       Date:  2016-01

Review 5.  Stressing Out Hsp90 in Neurotoxic Proteinopathies.

Authors:  Carmen Inda; Alexander Bolaender; Tai Wang; Srinivasa R Gandu; John Koren
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

6.  DnaJ-1 and karyopherin α3 suppress degeneration in a new Drosophila model of Spinocerebellar Ataxia Type 6.

Authors:  Wei-Ling Tsou; Ryan R Hosking; Aaron A Burr; Joanna R Sutton; Michelle Ouyang; Xiaofei Du; Christopher M Gomez; Sokol V Todi
Journal:  Hum Mol Genet       Date:  2015-05-07       Impact factor: 6.150

7.  Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention.

Authors:  Aaron Carman; Sarah Kishinevsky; John Koren; Wenjie Lou; Gabriela Chiosis
Journal:  J Alzheimers Dis Parkinsonism       Date:  2013-04

8.  Cytoplasmic location of α1A voltage-gated calcium channel C-terminal fragment (Cav2.1-CTF) aggregate is sufficient to cause cell death.

Authors:  Makoto Takahashi; Masato Obayashi; Taro Ishiguro; Nozomu Sato; Yusuke Niimi; Kokoro Ozaki; Kaoru Mogushi; Yasen Mahmut; Hiroshi Tanaka; Fuminori Tsuruta; Ricardo Dolmetsch; Mitsunori Yamada; Hitoshi Takahashi; Takeo Kato; Osamu Mori; Yoshinobu Eishi; Hidehiro Mizusawa; Kinya Ishikawa
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.